Shares of Elevance Health Inc. ELV slid 1.24% to $391.22 Tuesday, on what proved to be an all-around positive trading session ...

Health-care companies rose sharply amid strong earnings. Elevance Health, the health insurer formerly known as Anthem, posted fourth-quarter profit and revenue ahead of Wall Street targets ...

Elevance Health topped profit and revenue expectations for the fourth quarter and is guiding for more gains from premiums and products in the year ahead. The health insurer formerly known as ...

With its stock down 7.4% over the past three months, it is easy to disregard Elevance Health (NYSE:ELV). However, ...

S&P 500 notches closing record with focus on Trump comments, earnings January 24, 2025 Elevance Health on Thursday ... survey finds The Dow Jones Industrial Average and S&P 500 chalked up record ...

Elevance Health delivered earnings and 2025 guidance that broadly met analysts’ expectations, likely providing some relief to investors after a challenging quarter. The fourth-quarter results ...

Ryan Langston has given his Buy rating due to a combination of factors influencing Elevance ... Universal Health, and Addus Homecare. According to TipRanks, Langston has an average return of ...

In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Elevance Health (ELV – Research Report), with a price target of $501.00. The company’s shares closed ...

Elevance Health Inc. closed 31.17% below its 52-week high of $567.26, which the company reached on September 3rd.